Author:
Dong Hongbin,Nebert Daniel W.,Bruford Elspeth A.,Thompson David C.,Joenje Hans,Vasiliou Vasilis
Funder
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health
National Human Genome Research Institute
National Institute of Environmental Health Sciences
Wellcome Trust
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Genetics,Molecular Biology,Molecular Medicine
Reference90 articles.
1. Mathew CG. Fanconi anaemia genes and susceptibility to cancer. Oncogene. 2006;25(43):5875–84.
2. Barankin B, Metelitsa AI, Schloss EH, Wasel NR. Skin disorders in Ashkenazi Jews: a review. Int J Dermatol. 2005;44(8):630–5.
3. Tipping AJ, Pearson T, Morgan NV, Gibson RA, Kuyt LP, Havenga C, et al. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci U S A. 2001;98(10):5734–9.
4. Whitney MA, Jakobs P, Kaback M, Moses RE, Grompe M. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population. Hum Mutat. 1994;3(4):339–41.
5. Alter BP, and Kupfer G (1993–2015) Fanconi Anemia. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle. Available From
http://www.ncbi.nlm.nih.gov/books/NBK1401/
Access date February 7, 2013.
Cited by
127 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献